ENHANCING ONCOLOGY ANALYSIS WITH BUILT-IN KRAS ASSAY SOLUTIONS AND RAS ASSAYS

while in the promptly evolving area of oncology research, accurate and efficient mutation screening is critical for establishing specific therapies. The KRAS products and services Platform performs a pivotal purpose in this landscape by featuring thorough methods for KRAS mutation profiling and Evaluation. KRAS mutations, present in roughly ninety